Syngenta expects Chinese to OK GM corn embroiled in lawsuits

Syngenta AG expects to win Chinese government approval soon for imports of a type of genetically modified corn at the center of lawsuits over U.S. grain shipments rejected by Beijing, a company spokesman said on Friday.

Syngenta, one of the world’s largest seed companies, will make an announcement when it receives official documentation from China that Agrisure Viptera corn, known as MIR 162, has been cleared for import, spokesman Paul Minehart said. He declined further comment.

Approval would be significant because U.S. corn trading with China has essentially shut down since Beijing began turning away cargoes containing MIR 162 corn in November 2013.

Global grain handlers Cargill Inc and Archer Daniels Midland Co, along with dozens of U.S. farmers, have sued Syngenta for selling MIR 162 corn without obtaining import approval from China, a major buyer. They claim the company misled the farm industry about the timeline for approval.

In April 2014, the National Grain and Feed Association estimated that rejections of shipments containing MIR 162 corn cost the U.S. agriculture industry at least $1 billion.

Read full, original article: Syngenta sees China approving contentious GMO corn soon

 

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Cancer mRNA Vaccine Concept
'A new frontier': Though scorned by RFK Jr., personalized mRNA vaccine offers hope for many suffering from melanoma skin cancer
Screenshot-2026-10-22-at-12.45.14-PM
Pennsylvania tells doctors to prepare for a surge in newborn measles cases—a complication unseen in decades
Diet Soda with Measuring Tape 2
Science challenges anti-soda activists: No, sodas won’t make you fat
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Crimson Drips Over the White House
In Trump administration redirect, U.S. steers NIH sharply away from biodefense and pandemic preparedness
Screenshot 2026-10-16 at 5.38
PFAS in Agriculture: Science, Uncertainty, and Risk Communication
West-Virginia-SNAP-Water-Bottle-Sticker
A ‘shining success’ or 'empty promises’: Two years along, West Virginians assess MAHA’s food promises
Rustic Skillet of Raw Brains
‘Weird food’? Testicle- and brain-eating, supplement-gulping MAHA health food enthusiasts defend their ‘natural’ diets
Screenshot 2026-10-23 at 2.28
Climate disruption alert: Global emissions hold steady while Trump’s America fuels more warming
Healthy Food Sensitivity Test Collection
Viewpoint: That’ll be $300: The wellness industry’s junk science scam to ‘fix’ your immune system that isn’t broken
Strawberry Clamshell with Warning Sticker
Viewpoint: Activists hype ‘dangerous level’ of pesticide residues in Driscoll berries: Separating health concerns from fear-mongering
Prescription Capsules Scattered on Twenty-Dollar Bills
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it, Part 2
Government Briefing on Autism Trends
Viewpoint: ‘Statistical murder’: Kennedy’s expanding record of “duplicity and mendacity”
Author-Presenting-Good-Energy
'Disillusioned': Controversial RFK Jr. ally and MAHA leader Calley Means quits Trump advisory role
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.